Metropolitan Life Insurance Company (MetLife)’s Assembly Biosciences ASMB Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-769	Closed	-$152K	–	2539
2020 Q3	$152K	Hold	769	–	–	﹤0.01%	1952
2020 Q2	$215K	Hold	769	–	–	﹤0.01%	1746
2020 Q1	$137K	Buy	769 +180	+31%	+$38.6K	﹤0.01%	1834
2019 Q4	$145K	Hold	589	–	–	﹤0.01%	2120
2019 Q3	$69.5K	Hold	589	–	–	﹤0.01%	2459
2019 Q2	$95.4K	Hold	589	–	–	﹤0.01%	2329
2019 Q1	$139K	Hold	589	–	–	﹤0.01%	2125
2018 Q4	$160K	Hold	589	–	–	﹤0.01%	1951
2018 Q3	$263K	Buy	589 +149	+34%	+$69.8K	﹤0.01%	1825
2018 Q2	$207K	Hold	440	–	–	﹤0.01%	1922
2018 Q1	$259K	Hold	440	–	–	﹤0.01%	1725
2017 Q4	$239K	Sell	440 -429	-49%	-$194K	﹤0.01%	1796
2017 Q3	$364K	Hold	869	–	–	﹤0.01%	1894
2017 Q2	$215K	Buy	+869	New	+$245K	﹤0.01%	2289
2015 Q4	–	Sell	-99	Closed	-$11K	–	2583
2015 Q3	$11K	Sell	99 -1,068	-92%	-$188K	﹤0.01%	2675
2015 Q2	$270K	Buy	+1,167	New	+$225K	﹤0.01%	2191

Other funds holding ASMB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ASMB Position: Q4 2020 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 769 shares — an estimated $152K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ASMB in Q2 2015 and held it in 16 quarters. The position peaked at $364K in Q3 2017. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

Metropolitan Life Insurance Company (MetLife) reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 769 Assembly Biosciences shares in Q4 2020, an estimated $152K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Assembly Biosciences in Q2 2015 and held it in 16 quarters.
Metropolitan Life Insurance Company (MetLife)'s Assembly Biosciences position peaked at $364K in Q3 2017.
109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2020, filed 16 Feb 2021.